Clinical Trial Update: Evaluation of the Safety and Efficacy of the Second Dose of Tranexamic Acid [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the safety and efficacy of a second dose of tranexamic acid has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tranexamic Acid Condition Not Specified

Drugs mentioned

• TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Hamad Medical Corporation | Conditions: Tranexamic Acid | Phase 3 | Status: COMPLETED